AlphaFold predicted structure
IVNS1ABP · Q9Y6Y0

Mean pLDDT
84.7/ 100
Confident
642 residues
Confidence breakdown
- Very high(≥ 90)67%
- Confident(70–90)16%
- Low(50–70)5%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
influenza virus NS1A binding protein
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
COVID-19 research
UnknownPrimary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownimmunodeficiency 70
neurodegenerative disease
placental retention
nervous system benign neoplasm
response to antihypertensive drug
late-onset Alzheimers disease
dislocation
vertebral column disorder
femur fracture
chronic kidney disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Influenza virus NS1A-binding protein
Involved in many cell functions, including pre-mRNA splicing, the aryl hydrocarbon receptor (AHR) pathway, F-actin organization and protein ubiquitination. Plays a role in the dynamic organization of the actin skeleton as a stabilizer of actin filaments by association with F-actin through Kelch repeats (By similarity). Protects cells from cell death induced by actin destabilization (By similarity). Functions as modifier of the AHR/Aryl hydrocarbon receptor pathway increasing the concentration of AHR available to activate transcription (PubMed:16582008). In addition, functions as a negative regulator of BCR(KLHL20) E3 ubiquitin ligase complex to prevent ubiquitin-mediated proteolysis of PML and DAPK1, two tumor suppressors (PubMed:25619834). Inhibits pre-mRNA splicing (in vitro) (PubMed:9696811). May play a role in mRNA nuclear export (PubMed:30538201)
IVNS1ABP · Q9Y6Y0

Mean pLDDT
84.7/ 100
Confident
642 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0